DRSC/TRiP Functional Genomics Resources

powered by:
logo

back to: DIOPT - Ortholog Prediction Tool / DIOPT for Diseases and Traits


Protein Alignment LRP2 and Lrp2

DIOPT Version :10

Sequence 1:NP_004516.2 Gene:LRP2 / 4036 HGNCID:6694 Length:4655 Species:Homo sapiens
Sequence 2:NP_001074557.1 Gene:Lrp2 / 14725 MGIID:95794 Length:4660 Species:Mus musculus


Alignment Length:4665 Identity:3578/4665 - (76%)
Similarity:4082/4665 - (87%) Gaps:15/4665 - (0%)


- Green bases have known domain annotations that are detailed below.


Human     1 MDRGPAAVACTLLLALVACLAPASGQECDSAHFRCGSGHCIPADWRCDGTKDCSDDADEIGCAVV 65
            |:||.||.|..||||:.|||||.|||||.|.:|||.:|:||||.||||||:||.||.|||||...
Mouse     1 MERGAAAAAWMLLLAIAACLAPVSGQECGSGNFRCDNGYCIPASWRCDGTRDCLDDTDEIGCPPR 65

Human    66 TCQQGYFKCQSEGQCIPNSWVCDQDQDCDDGSDERQDCSQSTCSSHQITCSNGQCIPSEYRCDHV 130
            :|..|:|.|.:||.|||:|||||||:||.||:||:|:|..:||||.|:|||||||:|.|||||||
Mouse    66 SCGSGFFLCPAEGTCIPSSWVCDQDKDCSDGADEQQNCPGTTCSSQQLTCSNGQCVPIEYRCDHV 130

Human   131 RDCPDGADENDCQYPTCEQLTCDNGACYNTSQKCDWKVDCRDSSDEINCTEICLHNEFSCGNGEC 195
            .|||||:||.:|.||||:||||.||||||||||||.||||||||||.|||.:|...||.||:|||
Mouse   131 SDCPDGSDERNCYYPTCDQLTCANGACYNTSQKCDHKVDCRDSSDEANCTTLCSQKEFQCGSGEC 195

Human   196 IPRAYVCDHDNDCQDGSDEHACNYPTCGGYQFTCPSGRCIYQNWVCDGEDDCKDNGDEDGCESGP 260
            |.|||||||||||:|.||||.|||.||||:||||.:|:||.|||||||:|||:|:||||||||..
Mouse   196 ILRAYVCDHDNDCEDNSDEHNCNYDTCGGHQFTCSNGQCINQNWVCDGDDDCQDSGDEDGCESNQ 260

Human   261 HDVHKCSPREWSCPESGRCISIYKVCDGILDCPGREDENNTSTGKYCSMTLCSALNCQYQCHETP 325
            .. |.|.||||:||.||||||:.|||||:.|||..|||||.::|:||...|||.|||:||||:||
Mouse   261 RH-HTCYPREWACPGSGRCISMDKVCDGVPDCPEGEDENNATSGRYCGTGLCSILNCEYQCHQTP 324

Human   326 YGGACFCPPGYIINHNDSRTCVEFDDCQIWGICDQKCESRPGRHLCHCEEGYILERGQYCKANDS 390
            |||.||||||:|||.||||||::|||||||||||||||||.|||.|.|||||||||||:||:|||
Mouse   325 YGGECFCPPGHIINSNDSRTCIDFDDCQIWGICDQKCESRQGRHQCLCEEGYILERGQHCKSNDS 389

Human   391 FGEASIIFSNGRDLLIGDIHGRSFRILVESQNRGVAVGVAFHYHLQRVFWTDTVQNKVFSVDING 455
            |..||||||||||||:||:|||:||||.||:|||:.:||.|||...||||||.:|.||||.||||
Mouse   390 FSAASIIFSNGRDLLVGDLHGRNFRILAESKNRGIVMGVDFHYQKHRVFWTDPMQAKVFSTDING 454

Human   456 LNIQEVLNVSVETPENLAVDWVNNKIYLVETKVNRIDMVNLDGSYRVTLITENLGHPRGIAVDPT 520
            ||.||:||||::.||||||||:|||:|||||:|||||:|||:|:.||||||||||||||||:|||
Mouse   455 LNTQEILNVSIDAPENLAVDWINNKLYLVETRVNRIDVVNLEGNQRVTLITENLGHPRGIALDPT 519

Human   521 VGYLFFSDWESLSGEPKLERAFMDGSNRKDLVKTKLGWPAGVTLDMISKRVYWVDSRFDYIETVT 585
            |||||||||.||||:||:||||||||||||||.||||||||:|||::||||||||||:|||||||
Mouse   520 VGYLFFSDWGSLSGQPKVERAFMDGSNRKDLVTTKLGWPAGITLDLVSKRVYWVDSRYDYIETVT 584

Human   586 YDGIQRKTVVHGGSLIPHPFGVSLFEGQVFFTDWTKMAVLKANKFTETNPQVYYQASLRPYGVTV 650
            |||||||||..||||:|||||:||||..|||||||||||:||||||:||||||:|:||.|:||||
Mouse   585 YDGIQRKTVARGGSLVPHPFGISLFEEHVFFTDWTKMAVMKANKFTDTNPQVYHQSSLTPFGVTV 649

Human   651 YHSLRQPYATNPCKDNNGGCEQVCVLSHRTDNDGLGFRCKCTFGFQLDTDERHCIAVQNFLIFSS 715
            ||:||||.|||||.:|||||.|:|||||||||.|||:||||.|||:||.||.||:||:|||:|||
Mouse   650 YHALRQPNATNPCGNNNGGCAQICVLSHRTDNGGLGYRCKCEFGFELDADEHHCVAVKNFLLFSS 714

Human   716 QVAIRGIPFTLSTQEDVMVPVSGNPSFFVGIDFDAQDSTIFFSDMSKHMIFKQKIDGTGREILAA 780
            |.|:|||||||||||||||||:|:||||||||||||.||||:||:||::|::|||||||:|::.|
Mouse   715 QTAVRGIPFTLSTQEDVMVPVTGSPSFFVGIDFDAQHSTIFYSDLSKNIIYQQKIDGTGKEVITA 779

Human   781 NRVENVESLAFDWISKNLYWTDSHYKSISVMRLADKTRRTVVQYLNNPRSVVVHPFAGYLFFTDW 845
            ||::|||.|:|||||:||||||...||::||:||||:||.::..||||||:||||.|||:|.:||
Mouse   780 NRLQNVECLSFDWISRNLYWTDGGSKSVTVMKLADKSRRQIISNLNNPRSIVVHPAAGYMFLSDW 844

Human   846 FRPAKIMRAWSDGSHLLPVINTTLGWPNGLAIDWAASRLYWVDAYFDKIEHSTFDGLDRRRLGHI 910
            ||||||||||||||||:|::||:|||||||||||:.||||||||:|||||||..|||||:||||:
Mouse   845 FRPAKIMRAWSDGSHLMPIVNTSLGWPNGLAIDWSTSRLYWVDAFFDKIEHSNLDGLDRKRLGHV 909

Human   911 EQMTHPFGLAIFGEHLFFTDWRLGAIIRVRKADGGEMTVIRSGIAYILHLKSYDVNIQTGSNACN 975
            :||||||||.:|.:::|.|||||||||||||:|||:|||:|.||:.|:|:|:||.::|||:|.|:
Mouse   910 DQMTHPFGLTVFKDNVFLTDWRLGAIIRVRKSDGGDMTVVRRGISSIMHVKAYDADLQTGTNYCS 974

Human   976 QPTHPNGDCSHFCFPVPNFQRVCGCPYGMRLASNHLTCEGDPTNEPPTEQCGLFSFPCKNGRCVP 1040
            |.|||||||||||||||||||||||||||:|..:.:||||||..||||:|||..||||.||:|||
Mouse   975 QTTHPNGDCSHFCFPVPNFQRVCGCPYGMKLQRDQMTCEGDPAREPPTQQCGSSSFPCNNGKCVP 1039

Human  1041 NYYLCDGVDDCHDNSDEQLCGTLNNTCSSSAFTCGH-GECIPAHWRCDKRNDCVDGSDEHNCPTH 1104
            :.:.|||||||||||||..||.||||||||||||.| |:|||..|||||:|||:|||||.||||.
Mouse  1040 SIFRCDGVDDCHDNSDEHQCGALNNTCSSSAFTCVHGGQCIPGQWRCDKQNDCLDGSDEQNCPTR 1104

Human  1105 APAS-CLDTQYTCDNHQCISKNWVCDTDNDCGDGSDEKNCNSTETCQPSQFNCPNHRCIDLSFVC 1168
            :|:| |..|.:|||||.||.|.|||||||||.||||||||.::.||.|:||.||:||||...:||
Mouse  1105 SPSSTCPPTSFTCDNHMCIPKEWVCDTDNDCSDGSDEKNCQASGTCHPTQFRCPDHRCISPLYVC 1169

Human  1169 DGDKDCVDGSDEVGCVLNCTASQFKCASGDKCIGVTNRCDGVFDCSDNSDEAGCPTRPPGMCHSD 1233
            ||||||||||||.|||||||:||||||.|..||....|||||:||.|||||||||||||||||.|
Mouse  1170 DGDKDCVDGSDEAGCVLNCTSSQFKCADGSSCINSRYRCDGVYDCKDNSDEAGCPTRPPGMCHPD 1234

Human  1234 EFQCQEDGICIPNFWECDGHPDCLYGSDEHNACVPKTCPSSYFHCDNGNCIHRAWLCDRDNDCGD 1298
            |||||.||.||||.|||||||||:.||||||.||||||..|:|.|||||||:.:|:||.||||.|
Mouse  1235 EFQCQGDGTCIPNTWECDGHPDCIQGSDEHNGCVPKTCSPSHFLCDNGNCIYNSWVCDGDNDCRD 1299

Human  1299 MSDEKDCPTQPFRCPSWQWQCLGHNICVNLSVVCDGIFDCPNGTDESPLCNGNSCSDFNGGCTHE 1363
            ||||||||||||.|||.||||.|::||||||.:|||:||||||||||||||.:||..|||||||.
Mouse  1300 MSDEKDCPTQPFHCPSSQWQCPGYSICVNLSALCDGVFDCPNGTDESPLCNQDSCLHFNGGCTHR 1364

Human  1364 CVQEPFGAKCLCPLGFLLANDSKTCEDIDECDILGSCSQHCYNMRGSFRCSCDTGYMLESDGRTC 1428
            |:|.||||.|:||:|:.||||:|||||::||||.|.|||||.||||||||:||..|.||||||||
Mouse  1365 CIQGPFGATCVCPIGYQLANDTKTCEDVNECDIPGFCSQHCVNMRGSFRCACDPEYTLESDGRTC 1429

Human  1429 KVTASESLLLLVASQNKIIADSVTSQVHNIYSLVENGSYIVAVDFDSISGRIFWSDATQGKTWSA 1493
            ||||||:|||:|||::|||.|::|:..|||||||::.|::||:||||::||:||||..:||||||
Mouse  1430 KVTASENLLLVVASRDKIIMDNITAHTHNIYSLVQDVSFVVALDFDSVTGRVFWSDLLEGKTWSA 1494

Human  1494 FQNGTDRRVVFDSSIILTETIAIDWVGRNLYWTDYALETIEVSKIDGSHRTVLISKNLTNPRGLA 1558
            ||||||:|||.||.:.|||.||:||:|||:|||||.|||||||||||||||||||||:|.|||||
Mouse  1495 FQNGTDKRVVHDSGLSLTEMIAVDWIGRNIYWTDYTLETIEVSKIDGSHRTVLISKNVTKPRGLA 1559

Human  1559 LDPRMNEHLLFWSDWGHHPRIERASMDGSMRTVIVQDKIFWPCGLTIDYPNRLLYFMDSYLDYMD 1623
            |||||.::::||||||||||||||||||:|||||||:||:|||||:|||||||:||||:||||::
Mouse  1560 LDPRMGDNVMFWSDWGHHPRIERASMDGTMRTVIVQEKIYWPCGLSIDYPNRLIYFMDAYLDYIE 1624

Human  1624 FCDYNGHHRRQVIASDLIIRHPYALTLFEDSVYWTDRATRRVMRANKWHGGNQSVVMYNIQWPLG 1688
            ||||:|.:|||||||||::.||:|||||||||:||||.|.:||:||||||.|||||||::..|||
Mouse  1625 FCDYDGQNRRQVIASDLVLHHPHALTLFEDSVFWTDRGTHQVMQANKWHGRNQSVVMYSVPQPLG 1689

Human  1689 IVAVHPSKQPNSVNPCAFSRCSHLCLLSSQGPHFYSCVCPSGWSLSPDLLNCLRDDQPFLITVRQ 1753
            |:|:|||:||:|.||||.:.||||||||:|.|..|||.|||||:||.|.:||:|.||||||:||:
Mouse  1690 IIAIHPSRQPSSPNPCASATCSHLCLLSAQEPRHYSCACPSGWNLSDDSVNCVRGDQPFLISVRE 1754

Human  1754 HIIFGISLNPEVKSNDAMVPIAGIQNGLDVEFDDAEQYIYWVENPGEIHRVKTDGTNRTVFASIS 1818
            ::||||||:||||||||||||:|||:|.||||||:||:|||||||||||||||||:|||.||.:|
Mouse  1755 NVIFGISLDPEVKSNDAMVPISGIQHGYDVEFDDSEQFIYWVENPGEIHRVKTDGSNRTAFAPLS 1819

Human  1819 MVGPSMNLALDWISRNLYSTNPRTQSIEVLTLHGDIRYRKTLIANDGTALGVGFPIGITVDPARG 1883
            ::|.|:.|||||:|||:|.|.|.::|||||||.||.||.||||.||||.||||||:||.||||||
Mouse  1820 LLGSSLGLALDWVSRNIYYTTPASRSIEVLTLRGDTRYGKTLITNDGTPLGVGFPVGIAVDPARG 1884

Human  1884 KLYWSDQGTDSGVPAKIASANMDGTSVKTLFTGNLEHLECVTLDIEEQKLYWAVTGRGVIERGNV 1948
            ||||||.|||||||||||||||||||:|.|||||:||||.|||||:|||||||||.|||||||||
Mouse  1885 KLYWSDHGTDSGVPAKIASANMDGTSLKILFTGNMEHLEVVTLDIQEQKLYWAVTSRGVIERGNV 1949

Human  1949 DGTDRMILVHQLSHPWGIAVHDSFLYYTDEQYEVIERVDKATGANKIVLRDNVPNLRGLQVYHRR 2013
            |||:||||||.|:||||:.||.|||||:||||||||||||::|:||:|.|||:|.||||:|||.|
Mouse  1950 DGTERMILVHHLAHPWGLVVHGSFLYYSDEQYEVIERVDKSSGSNKVVFRDNIPYLRGLRVYHHR 2014

Human  2014 NAAESSNGCSNNMNACQQICLPVPGGLFSCACATGFKLNPDNRSCSPYNSFIVVSMLSAIRGFSL 2078
            |||:||||||||.|||||||||||||:||||||:||||:||.|||||||||||||||.|:|||||
Mouse  2015 NAADSSNGCSNNPNACQQICLPVPGGMFSCACASGFKLSPDGRSCSPYNSFIVVSMLPAVRGFSL 2079

Human  2079 ELSDHSETMVPVAGQGRNALHVDVDVSSGFIYWCDFSSSVASDNAIRRIKPDGSSLMNIVTHGIG 2143
            |||||||.||||||||||.||.||||::||||||||||||.|.|.||||||:||:..||||:|||
Mouse  2080 ELSDHSEAMVPVAGQGRNVLHADVDVANGFIYWCDFSSSVRSSNGIRRIKPNGSNFTNIVTYGIG 2144

Human  2144 ENGVRGIAVDWVAGNLYFTNAFVSETLIEVLRINTTYRRVLLKVTVDMPRHIVVDPKNRYLFWAD 2208
            .||:||:||||||||||||||||.||||||:|||||||||||||:||||||||||||:|||||||
Mouse  2145 ANGIRGVAVDWVAGNLYFTNAFVYETLIEVIRINTTYRRVLLKVSVDMPRHIVVDPKHRYLFWAD 2209

Human  2209 YGQRPKIERSFLDCTNRTVLVSEGIVTPRGLAVDRSDGYVYWVDDSLDIIARIRINGENSEVIRY 2273
            |||:||||||||||||||||||||||||||||||...||:|||||||||||||..:|..|:|:||
Mouse  2210 YGQKPKIERSFLDCTNRTVLVSEGIVTPRGLAVDHDTGYIYWVDDSLDIIARIHRDGGESQVVRY 2274

Human  2274 GSRYPTPYGITVFENSIIWVDRNLKKIFQASKEPENTEPPTVIRDNINWLRDVTIFDKQVQPRSP 2338
            |||||||||||||..|||||||||:|:|||||:|.||:|||||||:||.||||||||:.|||.||
Mouse  2275 GSRYPTPYGITVFGESIIWVDRNLRKVFQASKQPGNTDPPTVIRDSINLLRDVTIFDEHVQPLSP 2339

Human  2339 AEVNNNPCLENNGGCSHLCFALPGLHTPKCDCAFGTLQSDGKNCAISTENFLIFALSNSLRSLHL 2403
            ||:||||||::||||||.|||||.|.||||.||||||:.||||||.|.|:|||::|:|||||||.
Mouse  2340 AELNNNPCLQSNGGCSHFCFALPELPTPKCGCAFGTLEDDGKNCATSREDFLIYSLNNSLRSLHF 2404

Human  2404 DPENHSPPFQTINVERTVMSLDYDSVSDRIYFTQNLASGVGQISYATLSSGIHTPTVIASGIGTA 2468
            ||::|:.|||.|:||...::||||..::||:|||.|....|||||..|.||..:||::.|.||..
Mouse  2405 DPQDHNLPFQAISVEGMAIALDYDRRNNRIFFTQKLNPIRGQISYVNLYSGASSPTILLSNIGVT 2469

Human  2469 DGIAFDWITRRIYYSDYLNQMINSMAEDGSNRTVIARVPKPRAIVLDPCQGYLYWADWDTHAKIE 2533
            ||||||||.|||||||:.||.|||||||||||.|||||.||||||||||:||:||.||.|:||||
Mouse  2470 DGIAFDWINRRIYYSDFSNQTINSMAEDGSNRAVIARVSKPRAIVLDPCRGYMYWTDWGTNAKIE 2534

Human  2534 RATLGGNFRVPIVNSSLVMPSGLTLDYEEDLLYWVDASLQRIERSTLTGVDREVIVNAAVHAFGL 2598
            ||||||||||||||:|||.|:|||||.|.|||||.|||||:||||||||.:|||:::.|.|:|||
Mouse  2535 RATLGGNFRVPIVNTSLVWPNGLTLDLETDLLYWADASLQKIERSTLTGSNREVVISTAFHSFGL 2599

Human  2599 TLYGQYIYWTDLYTQRIYRANKYDGSGQIAMTTNLLSQPRGINTVVKNQKQQCNNPCEQFNGGCS 2663
            |:|||||||||.||::||||||||||..|||||.|.:||.||:||||.|:|||:|||:|||||||
Mouse  2600 TVYGQYIYWTDFYTKKIYRANKYDGSDLIAMTTRLPTQPSGISTVVKTQQQQCSNPCDQFNGGCS 2664

Human  2664 HICAPGPNGAECQCPHEGNWYLANNRKHCIVDNGERCGASSFTCSNGRCISEEWKCDNDNDCGDG 2728
            ||||||||||||||||||:|||||:.|:|:||.|.||....|||.||||||::||||||||||||
Mouse  2665 HICAPGPNGAECQCPHEGSWYLANDNKYCVVDTGARCNQFQFTCLNGRCISQDWKCDNDNDCGDG 2729

Human  2729 SDEMESVCALHTCSPTAFTCANGRCVQYSYRCDYYNDCGDGSDEAGCLFRDCNATTEFMCNNRRC 2793
            |||:.:|||.|||..|||||||||||.|.||||:||||||.|||||||||.||:||||.|:|.||
Mouse  2730 SDELPTVCAFHTCRSTAFTCANGRCVPYHYRCDFYNDCGDNSDEAGCLFRSCNSTTEFTCSNGRC 2794

Human  2794 IPREFICNGVDNCHDNNTSDEKNCPDRTCQSGYTKCHNSNICIPRVYLCDGDNDCGDNSDENPTY 2858
            ||..::|||::|||||:||||||||..|||..:.||..:|||:||.:||||||||||.|||||.|
Mouse  2795 IPLSYVCNGINNCHDNDTSDEKNCPPITCQPDFAKCQTTNICVPRAFLCDGDNDCGDGSDENPIY 2859

Human  2859 CTTHTCSSSEFQCAS-GRCIPQHWYCDQETDCFDASDEPASCGHSERTCLADEFKCDGGRCIPSE 2922
            |.:|||.|:||||.| .||||.:|:||.|.||.|:||||.:||||..:|.|::|.||.||||.|.
Mouse  2860 CASHTCRSNEFQCVSPHRCIPSYWFCDGEADCVDSSDEPDTCGHSLNSCSANQFHCDNGRCISSS 2924

Human  2923 WICDGDNDCGDMSDEDKRHQCQNQNCSDSEFLCVNDRPPDRRCIPQSWVCDGDVDCTDGYDENQN 2987
            |:||||||||||||||:||.|:.||||.:||.|:|.|||:||||||.||||||.||.|..||.||
Mouse  2925 WVCDGDNDCGDMSDEDQRHHCELQNCSSTEFTCINSRPPNRRCIPQHWVCDGDADCADALDELQN 2989

Human  2988 CTRRTCSENEFTCGYGLCIPKIFRCDRHNDCGDYSDERGCLYQTCQQNQFTCQNGRCISKTFVCD 3052
            ||.|.||..||:|..|.||.:.|||||.||||||||||||.|..|:.:|||||||:||:|.:|||
Mouse  2990 CTMRACSTGEFSCANGRCIRQSFRCDRRNDCGDYSDERGCSYPPCRDDQFTCQNGQCITKLYVCD 3054

Human  3053 EDNDCGDGSDELMHLCHTPEPTCPPHEFKCDNGRCIEMMKLCNHLDDCLDNSDEKGCGINECHDP 3117
            |||||||||||..|||||||||||||:|:||||.||||..:|||:|||.|||||||||||||.|.
Mouse  3055 EDNDCGDGSDEQEHLCHTPEPTCPPHQFRCDNGHCIEMGTVCNHVDDCSDNSDEKGCGINECQDS 3119

Human  3118 SISGCDHNCTDTLTSFYCSCRPGYKLMSDKRTCVDIDECTEMPFVCSQKCENVIGSYICKCAPGY 3182
            |||.||||||||:|||||||.||||||||||||||||||.|.|.:||||||||||||||||||||
Mouse  3120 SISHCDHNCTDTITSFYCSCLPGYKLMSDKRTCVDIDECKETPQLCSQKCENVIGSYICKCAPGY 3184

Human  3183 LREPDGKTCRQNSNIEPYLIFSNRYYLRNLTIDGYFYSLILEGLDNVVALDFDRVEKRLYWIDTQ 3247
            :||||||:|||||||||||:||||||:|||||||..|||||:||.|||||||||||:||||||.:
Mouse  3185 IREPDGKSCRQNSNIEPYLVFSNRYYIRNLTIDGTSYSLILQGLGNVVALDFDRVEERLYWIDAE 3249

Human  3248 RQVIERMFLNKTNKETIINHRLPAAESLAVDWVSRKLYWLDARLDGLFVSDLNGGHRRMLAQHCV 3312
            :|:||||||||||:||||:|||..||||||||||||||||||.||.||||||.|..|:|||||||
Mouse  3250 KQIIERMFLNKTNQETIISHRLRRAESLAVDWVSRKLYWLDAILDCLFVSDLEGRQRKMLAQHCV 3314

Human  3313 DANNTFCFDNPRGLALHPQYGYLYWADWGHRAYIGRVGMDGTNKSVIISTKLEWPNGITIDYTND 3377
            ||||||||:||||:.||||.||:||||||..|||.|:|||||||:||||||:||||.||||||||
Mouse  3315 DANNTFCFENPRGIVLHPQRGYVYWADWGDHAYIARIGMDGTNKTVIISTKIEWPNAITIDYTND 3379

Human  3378 LLYWADAHLGYIEYSDLEGHHRHTVYDGALPHPFAITIFEDTIYWTDWNTRTVEKGNKYDGSNRQ 3442
            |||||||||||||:||||||||||||||.||||||:||||||::||||||||||||||||||.|.
Mouse  3380 LLYWADAHLGYIEFSDLEGHHRHTVYDGTLPHPFALTIFEDTVFWTDWNTRTVEKGNKYDGSGRV 3444

Human  3443 TLVNTTHRPFDIHVYHPYRQPIVSNPCGTNNGGCSHLCLIKPGGKGFTCECPDDFRTLQLSGSTY 3507
            .||||||:||||||.|||||||:||||.|||||||||||||.||:||||||||||:|:||...|.
Mouse  3445 VLVNTTHKPFDIHVLHPYRQPIMSNPCATNNGGCSHLCLIKAGGRGFTCECPDDFQTVQLRDRTL 3509

Human  3508 CMPMCSSTQFLCANNEKCIPIWWKCDGQKDCSDGSDELALCPQRFCRLGQFQCSDGNCTSPQTLC 3572
            ||||||||||||.||||||||||||||||||||||||..|||.||||||||||.||||||||.||
Mouse  3510 CMPMCSSTQFLCGNNEKCIPIWWKCDGQKDCSDGSDESDLCPHRFCRLGQFQCRDGNCTSPQALC 3574

Human  3573 NAHQNCPDGSDEDRLLCENHHCDSNEWQCANKRCIPESWQCDTFNDCEDNSDEDSSHCASRTCRP 3637
            ||.|:|.|||||||:|||:|.|::|||||||||||||.||||:.:||.||||||.||||||||||
Mouse  3575 NARQDCADGSDEDRVLCEHHRCEANEWQCANKRCIPEYWQCDSVDDCLDNSDEDPSHCASRTCRP 3639

Human  3638 GQFRCANGRCIPQAWKCDVDNDCGDHSDEPIEECMSSAHLCDNFTEFSCKTNYRCIPKWAVCNGV 3702
            |||:|.|||||||:|||||||||||:|||||.|||::|:.|||.|||||||||||||:||||||.
Mouse  3640 GQFKCNNGRCIPQSWKCDVDNDCGDYSDEPIHECMTAAYNCDNHTEFSCKTNYRCIPQWAVCNGF 3704

Human  3703 DDCRDNSDEQGCEERTCHPVGDFRCKNHHCIPLRWQCDGQNDCGDNSDEENCAPRECTESEFRCV 3767
            |||||||||||||...|||.|||||.|||||||||:|||.:|||||||||:|.|||||||||||.
Mouse  3705 DDCRDNSDEQGCESVPCHPSGDFRCGNHHCIPLRWKCDGIDDCGDNSDEESCVPRECTESEFRCA 3769

Human  3768 NQQCIPSRWICDHYNDCGDNSDERDCEMRTCHPEYFQCTSGHCVHSELKCDGSADCLDASDEADC 3832
            :||||||||:||..||||||||||||||:|||||:|||||||||...|.|||.|||||||||:.|
Mouse  3770 DQQCIPSRWVCDQENDCGDNSDERDCEMKTCHPEHFQCTSGHCVPKALACDGRADCLDASDESAC 3834

Human  3833 PTRFPDGAYCQATMFECKNHVCIPPYWKCDGDDDCGDGSDEELHLCLDVPCNSPNRFRCDNNRCI 3897
            |||||:|.||.|.||||||||||..:|.|||::||.||||||:|||.:|||.||.||||||:|||
Mouse  3835 PTRFPNGTYCPAAMFECKNHVCIQSFWICDGENDCVDGSDEEIHLCFNVPCESPQRFRCDNSRCI 3899

Human  3898 YSHEVCNGVDDCGDGTDETEEHCRKPTPKPCTEYEYKCGNGHCIPHDNVCDDADDCGDWSDELGC 3962
            |.|::||||||||||:||.||||||||.||||:.||||.||:|:....|||:.|||||.|||.||
Mouse  3900 YGHQLCNGVDDCGDGSDEKEEHCRKPTHKPCTDTEYKCSNGNCVSQHYVCDNVDDCGDLSDETGC 3964

Human  3963 NKGKERTCAENICEQNCTQLNEGGFICSCTAGFETNVFDRTSCLDINECEQFGTCPQHCRNTKGS 4027
            |.|:.|||||.|||||||||:.|||||||..||:.:..|:.||.||||||:||.|||.|||:|||
Mouse  3965 NLGENRTCAEKICEQNCTQLSNGGFICSCRPGFKPSTLDKNSCQDINECEEFGICPQSCRNSKGS 4029

Human  4028 YECVCADGFTSMSDRPGKRCAAEGSSPLLLLPDNVRIRKYNLSSERFSEYLQDEEYIQAVDYDWD 4092
            |||.|.|||.|||...|:||||:||.||||||:||||||||:|||:|||||::||:|||:|||||
Mouse  4030 YECFCVDGFKSMSTHYGERCAADGSPPLLLLPENVRIRKYNISSEKFSEYLEEEEHIQAIDYDWD 4094

Human  4093 PKDIGLSVVYYTVRGEGSRFGAIKRAYIPNFESGRNNLVQEVDLKLKYVMQPDGIAVDWVGRHIY 4157
            |:.||||||||||..:||:||||||||:|:||||.||.|:||||.|||:|||||:||||||||||
Mouse  4095 PEGIGLSVVYYTVLSQGSQFGAIKRAYLPDFESGSNNPVREVDLGLKYLMQPDGLAVDWVGRHIY 4159

Human  4158 WSDVKNKRIEVAKLDGRYRKWLISTDLDQPAAIAVNPKLGLMFWTDWGKEPKIESAWMNGEDRNI 4222
            |||.|::|||||.||||||||||:|.||||||||||||||||||||.||:|||||||||||.|::
Mouse  4160 WSDAKSQRIEVATLDGRYRKWLITTQLDQPAAIAVNPKLGLMFWTDQGKQPKIESAWMNGEHRSV 4224

Human  4223 LVFEDLGWPTGLSIDYLNNDRIYWSDFKEDVIETIKYDGTDRRVIAKEAMNPYSLDIFEDQLYWI 4287
            |...:||||.||||||||.|||||||.||||||:|||||||||:|..:||.|:|||||||||||:
Mouse  4225 LASANLGWPNGLSIDYLNGDRIYWSDSKEDVIESIKYDGTDRRLIINDAMKPFSLDIFEDQLYWV 4289

Human  4288 SKEKGEVWKQNKFGQGKKEKTLVVNPWLTQVRIFHQLRYNKSVPNLCKQICSHLCLLRPGGYSCA 4352
            :|||||||:|||||:|.|||.|||||||||||||||||||:||.|.|||:|||||||||||||||
Mouse  4290 AKEKGEVWRQNKFGKGNKEKLLVVNPWLTQVRIFHQLRYNQSVSNPCKQVCSHLCLLRPGGYSCA 4354

Human  4353 CPQGSSFIEGSTTECDAAIELPINLPPPCRCMHGGNCYFDETDLPKCKCPSGYTGKYCEMAFSKG 4417
            |||||.|:.|||.|||||.||||.:|.||||||||:|||||.|||||||.|||:|:|||:..|:|
Mouse  4355 CPQGSDFVTGSTVECDAASELPITMPSPCRCMHGGSCYFDENDLPKCKCSSGYSGEYCEIGLSRG 4419

Human  4418 ISPGTTAVAVLLTILLIVVIGALAIAGFFHYRRTGSLLPALPKLPSLSSLVKPSENGNGVTFRSG 4482
            |.|||| :|:|||..:::::|||.:.||||||:||||||:||||||||||.||||||||||||||
Mouse  4420 IPPGTT-MALLLTFAMVIIVGALVLVGFFHYRKTGSLLPSLPKLPSLSSLAKPSENGNGVTFRSG 4483

Human  4483 ADLNMDIGVSGFGPETAIDRSMAMSEDFVMEMGKQPIIFENPMYSARDSAVKVVQPI-------Q 4540
            ||:|||||||.|||||.|||||||:|.||||:||||:|||||||:|:||..||...:       |
Mouse  4484 ADVNMDIGVSPFGPETIIDRSMAMNEQFVMEVGKQPVIFENPMYAAKDSTSKVGLAVQGPSVSSQ 4548

Human  4541 VTVSENVDNKNYGSPINPSEIVPETNPTSPAADGTQVTKWNLFKRKSKQTTNFENPIYAQMENEQ 4605
            |||.|||:|:|||..|:|||||||..|.||.||.||.||||:||||.||||||||||||:|:.||
Mouse  4549 VTVPENVENQNYGRSIDPSEIVPEPKPASPGADETQGTKWNIFKRKPKQTTNFENPIYAEMDTEQ 4613

Human  4606 KESVAATPPPSPSLPAKPKPPSRRDPTPTYSATEDTFKDTANLVKEDSEV 4655
            ||:||..||||||||||   .|:|..||.|:|||||||||||||||||:|
Mouse  4614 KEAVAVAPPPSPSLPAK---ASKRSSTPGYTATEDTFKDTANLVKEDSDV 4660

Known Domains:


Indicated by green bases in alignment.

GeneSequenceDomainRegion External IDIdentity
LRP2NP_004516.2 LDLa 28..62 CDD:238060 23/33 (70%)
LDLa 108..142 CDD:238060 26/33 (79%)
LDLa 149..179 CDD:238060 26/29 (90%)
LDLa 183..217 CDD:238060 25/33 (76%)
LDLa 222..256 CDD:238060 25/33 (76%)
LDLa 266..300 CDD:238060 24/33 (73%)
YncE 394..579 CDD:442618 148/184 (80%)
LDL-receptor class B 1. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 436..478 31/41 (76%)
LDL-receptor class B 2. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 479..521 34/41 (83%)
LY 503..548 CDD:214531 40/44 (91%)
LDL-receptor class B 3. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 522..568 39/45 (87%)
LY 551..591 CDD:214531 34/39 (87%)
LDL-receptor class B 4. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 569..613 38/43 (88%)
FXa_inhibition 663..704 CDD:464251 30/40 (75%)
LDL-receptor class B 5. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 753..795 27/41 (66%)
LY 776..818 CDD:214531 27/41 (66%)
LDL-receptor class B 6. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 796..837 26/40 (65%)
LDL-receptor class B 7. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 838..881 35/42 (83%)
Ldl_recept_b 838..879 CDD:459654 33/40 (83%)
LY 864..904 CDD:214531 31/39 (79%)
LDL-receptor class B 8. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 882..925 33/42 (79%)
FXa_inhibition 981..1013 CDD:464251 25/31 (81%)
LDLa 1026..1060 CDD:238060 24/33 (73%)
LDLa 1067..1101 CDD:238060 26/34 (76%)
LDLa 1109..1143 CDD:238060 25/33 (76%)
LDLa 1149..1183 CDD:238060 24/33 (73%)
LDLa 1187..1222 CDD:238060 24/34 (71%)
LDLa 1230..1264 CDD:238060 27/33 (82%)
LDLa 1271..1305 CDD:238060 23/33 (70%)
LDLa 1311..1344 CDD:197566 24/32 (75%)
FXa_inhibition 1353..1388 CDD:464251 23/34 (68%)
EGF_CA 1390..1429 CDD:214542 29/38 (76%)
LY 1461..1500 CDD:214531 26/38 (68%)
LDL-receptor class B 9. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1478..1520 30/41 (73%)
LY 1501..1543 CDD:214531 32/41 (78%)
LDL-receptor class B 10. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1521..1563 37/41 (90%)
LY 1545..1589 CDD:214531 35/43 (81%)
LDL-receptor class B 11. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1566..1609 35/42 (83%)
LY 1591..1632 CDD:214531 31/40 (78%)
LDL-receptor class B 12. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1610..1654 32/43 (74%)
LDL-receptor class B 13. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1655..1695 27/39 (69%)
YvrE 1787..>1951 CDD:442613 131/163 (80%)
LDL-receptor class B 14. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1790..1832 31/41 (76%)
LDL-receptor class B 15. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1833..1882 35/48 (73%)
LDL-receptor class B 16. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1883..1930 41/46 (89%)
Ldl_recept_b 1883..1928 CDD:459654 39/44 (89%)
LY 1911..1953 CDD:214531 36/41 (88%)
LDL-receptor class B 17. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1931..1972 33/40 (83%)
LDL-receptor class B 18. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1973..2013 30/39 (77%)
FXa_inhibition 2022..2058 CDD:464251 30/35 (86%)
YncE <2091..2252 CDD:442618 136/160 (85%)
LDL-receptor class B 19. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2107..2156 37/48 (77%)
LDL-receptor class B 20. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2157..2201 40/43 (93%)
LDL-receptor class B 21. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2202..2245 40/42 (95%)
LY 2227..2267 CDD:214531 32/39 (82%)
Vgb 2236..2544 CDD:443399 224/307 (73%)
LDL-receptor class B 22. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2246..2289 33/42 (79%)
LDL-receptor class B 23. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2431..2477 26/45 (58%)
LY 2459..2500 CDD:214531 30/40 (75%)
LDL-receptor class B 24. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2478..2518 34/39 (87%)
LY 2500..2542 CDD:214531 34/41 (83%)
LDL-receptor class B 25. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2519..2562 34/42 (81%)
LY 2545..2585 CDD:214531 31/39 (79%)
LDL-receptor class B 26. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2563..2604 29/40 (73%)
LY <2593..2625 CDD:214531 25/31 (81%)
LDL-receptor class B 27. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2605..2646 30/40 (75%)
FXa_inhibition 2655..2692 CDD:464251 32/36 (89%)
LDLa 2700..2732 CDD:238060 24/31 (77%)
LDLa 2741..2775 CDD:238060 27/33 (82%)
LDLa 2784..2817 CDD:238060 22/32 (69%)
LDLa 2821..2854 CDD:197566 21/32 (66%)
Ldl_recept_a 2863..2895 CDD:395011 20/32 (63%)
LDLa 2905..2937 CDD:197566 22/31 (71%)
LDLa 2948..2988 CDD:238060 27/39 (69%)
LDLa 2993..3027 CDD:238060 23/33 (70%)
LDLa 3031..3063 CDD:197566 23/31 (74%)
LDLa 3075..3109 CDD:238060 25/33 (76%)
FXa_inhibition 3121..3150 CDD:464251 25/28 (89%)
vWFA <3147..3190 CDD:469594 37/42 (88%)
LY 3219..3260 CDD:214531 33/40 (83%)
LDL-receptor class B 28. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 3239..3281 32/41 (78%)
LY 3262..3304 CDD:214531 34/41 (83%)
Ldl_recept_b 3282..3330 CDD:459654 38/47 (81%)
LDL-receptor class B 29. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 3282..3324 34/41 (83%)
LDL-receptor class B 30. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 3333..3376 34/42 (81%)
Ldl_recept_b 3333..3374 CDD:459654 32/40 (80%)
LY 3358..3399 CDD:214531 37/40 (93%)
LDL-receptor class B 31. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 3377..3419 38/41 (93%)
LY <3408..3441 CDD:214531 29/32 (91%)
LDL-receptor class B 32. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 3420..3460 32/39 (82%)
FXa_inhibition 3469..>3498 CDD:464251 25/28 (89%)
LDLa 3512..3544 CDD:197566 30/31 (97%)
LDLa 3553..3584 CDD:197566 25/30 (83%)
LDLa 3594..3626 CDD:238060 24/31 (77%)
LDLa 3634..3666 CDD:197566 27/31 (87%)
LDLa 3682..3714 CDD:238060 29/31 (94%)
LDLa 3719..3754 CDD:238060 29/34 (85%)
LDLa 3759..3793 CDD:238060 28/33 (85%)
LDLa 3798..3832 CDD:238060 26/33 (79%)
LDLa 3885..3915 CDD:197566 23/29 (79%)
LDLa 3928..3962 CDD:238060 20/33 (61%)
EGF_CA 4007..4047 CDD:214542 28/39 (72%)
LY 4141..4176 CDD:214531 28/34 (82%)
LDL-receptor class B 33. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 4154..4196 35/41 (85%)
LDL-receptor class B 34. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 4197..4240 32/42 (76%)
Ldl_recept_b 4197..4238 CDD:459654 30/40 (75%)
LY 4222..4264 CDD:214531 32/41 (78%)
LDL-receptor class B 35. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 4242..4283 32/40 (80%)
FXa_inhibition 4338..>4356 CDD:464251 17/17 (100%)
SH3-binding. /evidence=ECO:0000255 4453..4462 7/8 (88%)
PxLPxI/L motif 1, mediates interaction with ANKRA2. /evidence=ECO:0000250|UniProtKB:P98158 4456..4461 3/4 (75%)
PxLPxI/L motif 2, mediates interaction with ANKRA2. /evidence=ECO:0000250|UniProtKB:P98158 4459..4464 4/4 (100%)
Endocytosis signal. /evidence=ECO:0000255 4521..4526 4/4 (100%)
Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite 4550..4574 15/23 (65%)
Interaction with DAB2. /evidence=ECO:0000269|PubMed:10769163 4589..4602 11/12 (92%)
NPXY motif 4595..4598 2/2 (100%)
SH2-binding. /evidence=ECO:0000255 4598..4601 2/2 (100%)
Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite 4601..4655 39/53 (74%)
SH3-binding. /evidence=ECO:0000255 4611..4622 8/10 (80%)
Lrp2NP_001074557.1 LDLa 28..62 CDD:238060 23/33 (70%)
LDLa 67..99 CDD:197566 20/31 (65%)
LDLa 108..142 CDD:238060 26/33 (79%)
LDLa 148..179 CDD:238060 26/30 (87%)
LDLa 183..217 CDD:238060 25/33 (76%)
LDLa 222..256 CDD:238060 25/33 (76%)
LDLa 265..299 CDD:238060 24/33 (73%)
YncE <427..576 CDD:442618 120/148 (81%)
LDL-receptor class B 1. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 435..477 31/41 (76%)
LDL-receptor class B 2. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 478..520 34/41 (83%)
LY 502..547 CDD:214531 40/44 (91%)
LDL-receptor class B 3. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 521..567 39/45 (87%)
LY 550..590 CDD:214531 34/39 (87%)
LDL-receptor class B 4. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 568..612 38/43 (88%)
FXa_inhibition 662..703 CDD:464251 30/40 (75%)
LDL-receptor class B 5. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 752..794 27/41 (66%)
LY 775..817 CDD:214531 27/41 (66%)
LDL-receptor class B 6. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 795..836 26/40 (65%)
LDL-receptor class B 7. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 837..880 35/42 (83%)
Ldl_recept_b 837..878 CDD:459654 33/40 (83%)
LY 863..903 CDD:214531 31/39 (79%)
LDL-receptor class B 8. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 881..924 33/42 (79%)
FXa_inhibition 980..1012 CDD:464251 25/31 (81%)
LDLa 1025..1059 CDD:238060 24/33 (73%)
Ldl_recept_a 1065..1101 CDD:395011 27/35 (77%)
LDLa 1110..1144 CDD:238060 25/33 (76%)
LDLa 1150..1184 CDD:238060 24/33 (73%)
LDLa 1188..1223 CDD:238060 24/34 (71%)
LDLa 1231..1263 CDD:197566 25/31 (81%)
LDLa 1272..1306 CDD:238060 23/33 (70%)
LDLa 1313..1345 CDD:197566 24/31 (77%)
FXa_inhibition 1354..1389 CDD:464251 23/34 (68%)
EGF_CA 1391..1430 CDD:214542 29/38 (76%)
LDL-receptor class B 9. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1479..1521 30/41 (73%)
LY 1502..1544 CDD:214531 32/41 (78%)
LDL-receptor class B 10. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1522..1564 37/41 (90%)
LY 1546..1590 CDD:214531 35/43 (81%)
LDL-receptor class B 11. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1567..1610 35/42 (83%)
LY 1592..1633 CDD:214531 31/40 (78%)
LDL-receptor class B 12. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1611..1655 32/43 (74%)
LDL-receptor class B 13. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1656..1696 27/39 (69%)
FXa_inhibition 1710..1741 CDD:464251 21/30 (70%)
LDL-receptor class B 14. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1791..1833 31/41 (76%)
LDL-receptor class B 15. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1834..1883 35/48 (73%)
LDL-receptor class B 16. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1884..1931 41/46 (89%)
Ldl_recept_b 1884..1929 CDD:459654 39/44 (89%)
LY 1912..1954 CDD:214531 36/41 (88%)
LDL-receptor class B 17. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1932..1973 33/40 (83%)
LDL-receptor class B 18. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 1974..2014 30/39 (77%)
YncE 2035..2277 CDD:442618 203/241 (84%)
LDL-receptor class B 19. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2108..2157 37/48 (77%)
LDL-receptor class B 20. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2158..2202 40/43 (93%)
LY 2183..2226 CDD:214531 39/42 (93%)
LDL-receptor class B 21. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2203..2246 40/42 (95%)
LDL-receptor class B 22. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2247..2290 33/42 (79%)
LDL-receptor class B 23. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2291..2333 34/41 (83%)
FXa_inhibition 2347..2383 CDD:464251 27/35 (77%)
LDL-receptor class B 24. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2432..2478 26/45 (58%)
LY 2460..2501 CDD:214531 30/40 (75%)
LDL-receptor class B 25. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2479..2519 34/39 (87%)
LY 2503..2543 CDD:214531 33/39 (85%)
LDL-receptor class B 26. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2520..2563 34/42 (81%)
LDL-receptor class B 27. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2564..2605 29/40 (73%)
LY <2595..2626 CDD:214531 25/30 (83%)
LDL-receptor class B 28. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 2606..2647 30/40 (75%)
FXa_inhibition 2656..2693 CDD:464251 32/36 (89%)
LDLa 2700..2732 CDD:197566 24/31 (77%)
LDLa 2742..2776 CDD:238060 27/33 (82%)
LDLa 2783..2818 CDD:238060 23/34 (68%)
LDLa 2822..2855 CDD:197566 21/32 (66%)
LDLa 2865..2899 CDD:238060 21/33 (64%)
LDLa 2908..2939 CDD:197566 22/30 (73%)
LDLa 2950..2986 CDD:197566 24/35 (69%)
LDLa 2995..3029 CDD:238060 23/33 (70%)
LDLa 3034..3066 CDD:238060 24/31 (77%)
LDLa 3077..3111 CDD:238060 25/33 (76%)
FXa_inhibition 3124..3152 CDD:464251 25/27 (93%)
vWFA <3149..3192 CDD:469594 37/42 (88%)
LY 3221..3262 CDD:214531 33/40 (83%)
LDL-receptor class B 29. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 3241..3283 32/41 (78%)
LY 3264..3306 CDD:214531 34/41 (83%)
Ldl_recept_b 3284..3332 CDD:459654 38/47 (81%)
LDL-receptor class B 30. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 3284..3326 34/41 (83%)
LDL-receptor class B 31. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 3335..3378 34/42 (81%)
Ldl_recept_b 3335..3376 CDD:459654 32/40 (80%)
LY 3360..3401 CDD:214531 37/40 (93%)
LDL-receptor class B 32. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 3379..3421 38/41 (93%)
LY 3406..3443 CDD:214531 32/36 (89%)
LDL-receptor class B 33. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 3422..3462 32/39 (82%)
FXa_inhibition 3471..>3500 CDD:464251 25/28 (89%)
LDLa 3514..3548 CDD:238060 32/33 (97%)
LDLa 3555..3586 CDD:197566 25/30 (83%)
LDLa 3595..3627 CDD:197566 23/31 (74%)
LDLa 3636..3668 CDD:197566 27/31 (87%)
LDLa 3684..3716 CDD:238060 29/31 (94%)
LDLa 3723..3756 CDD:238060 27/32 (84%)
LDLa 3761..3795 CDD:238060 28/33 (85%)
LDLa 3800..3834 CDD:238060 26/33 (79%)
LDLa 3844..3876 CDD:238060 22/31 (71%)
LDLa 3887..3917 CDD:197566 23/29 (79%)
LDLa 3930..3964 CDD:238060 20/33 (61%)
EGF_CA 4009..4049 CDD:214542 28/39 (72%)
LY 4143..4178 CDD:214531 28/34 (82%)
LDL-receptor class B 34. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 4156..4198 35/41 (85%)
LDL-receptor class B 35. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 4199..4242 32/42 (76%)
Ldl_recept_b 4199..4240 CDD:459654 30/40 (75%)
LY 4224..4266 CDD:214531 32/41 (78%)
LDL-receptor class B 36. /evidence=ECO:0000255|PROSITE-ProRule:PRU00461 4244..4285 32/40 (80%)
FXa_inhibition 4340..>4358 CDD:464251 17/17 (100%)
SH3-binding. /evidence=ECO:0000255 4454..4463 7/8 (88%)
PxLPxI/L motif 1, mediates interaction with ANKRA2. /evidence=ECO:0000250|UniProtKB:P98158 4457..4462 3/4 (75%)
PxLPxI/L motif 2, mediates interaction with ANKRA2. /evidence=ECO:0000250|UniProtKB:P98158 4460..4465 4/4 (100%)
Endocytosis signal. /evidence=ECO:0000255 4522..4527 4/4 (100%)
Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite 4558..4660 77/104 (74%)
Interaction with DAB2. /evidence=ECO:0000250|UniProtKB:P98164 4597..4610 11/12 (92%)
NPXY motif 4603..4606 2/2 (100%)
SH2-binding. /evidence=ECO:0000255 4606..4609 2/2 (100%)
SH3-binding. /evidence=ECO:0000255 4619..4630 8/10 (80%)

Return to query results.
Submit another query.